Literature DB >> 29904729

Proteome-wide analysis of protein abundance and turnover remodelling during oncogenic transformation of human breast epithelial cells.

Tony Ly1,2,3, Aki Endo1,2,4, Alejandro Brenes1,2, Marek Gierlinski1,2, Vackar Afzal1,2, Andrea Pawellek1,2, Angus I Lamond1,2.   

Abstract

Background: Viral oncogenes and mutated proto-oncogenes are potent drivers of cancer malignancy. Downstream of the oncogenic trigger are alterations in protein properties that give rise to cellular transformation and the acquisition of malignant cellular phenotypes. Developments in mass spectrometry enable large-scale, multidimensional characterisation of proteomes. Such techniques could provide an unprecedented, unbiased view of how oncogene activation remodels a human cell proteome.
Methods: Using quantitative MS-based proteomics and cellular assays, we analysed how transformation induced by activating v-Src kinase remodels the proteome and cellular phenotypes of breast epithelial (MCF10A) cells. SILAC MS was used to comprehensively characterise the MCF10A proteome and to measure v-Src-induced changes in protein abundance across seven time-points (1-72 hrs). We used pulse-SILAC MS ( Boisvert et al., 2012), to compare protein synthesis and turnover in control and transformed cells. Follow-on experiments employed a combination of cellular and functional assays to characterise the roles of selected Src-responsive proteins.
Results: Src-induced transformation changed the expression and/or turnover levels of ~3% of proteins, affecting ~1.5% of the total protein molecules in the cell. Transformation increased the average rate of proteome turnover and disrupted protein homeostasis. We identify distinct classes of protein kinetics in response to Src activation. We demonstrate that members of the polycomb repressive complex 1 (PRC1) are important regulators of invasion and migration in MCF10A cells. Many Src-regulated proteins are present in low abundance and some are regulated post-transcriptionally. The signature of Src-responsive proteins is highly predictive of poor patient survival across multiple cancer types. Open access to search and interactively explore all these proteomic data is provided via the EPD database ( www.peptracker.com/epd). Conclusions: We present the first comprehensive analysis measuring how protein expression and protein turnover is affected by cell transformation, providing a detailed picture at the protein level of the consequences of activation of an oncogene.

Entities:  

Keywords:  Biomarker; Cancer; Epigenetic; Polycomb Repressive Complex (PRC); Protein half-life; Serine protease inhibitor (Serpin); Src Kinase; Time-lapse Proteomics

Year:  2018        PMID: 29904729      PMCID: PMC5989152          DOI: 10.12688/wellcomeopenres.14392.1

Source DB:  PubMed          Journal:  Wellcome Open Res        ISSN: 2398-502X


  73 in total

1.  Mechanisms of insulin-induced insulin-receptor downregulation. Decrease of receptor biosynthesis and mRNA levels.

Authors:  Y Okabayashi; B A Maddux; A R McDonald; C D Logsdon; J A Williams; I D Goldfine
Journal:  Diabetes       Date:  1989-02       Impact factor: 9.461

Review 2.  A perspective on cancer cell metastasis.

Authors:  Christine L Chaffer; Robert A Weinberg
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

Review 3.  Multidimensional proteomics for cell biology.

Authors:  Mark Larance; Angus I Lamond
Journal:  Nat Rev Mol Cell Biol       Date:  2015-04-10       Impact factor: 94.444

4.  A pathology atlas of the human cancer transcriptome.

Authors:  Mathias Uhlen; Cheng Zhang; Sunjae Lee; Evelina Sjöstedt; Linn Fagerberg; Gholamreza Bidkhori; Rui Benfeitas; Muhammad Arif; Zhengtao Liu; Fredrik Edfors; Kemal Sanli; Kalle von Feilitzen; Per Oksvold; Emma Lundberg; Sophia Hober; Peter Nilsson; Johanna Mattsson; Jochen M Schwenk; Hans Brunnström; Bengt Glimelius; Tobias Sjöblom; Per-Henrik Edqvist; Dijana Djureinovic; Patrick Micke; Cecilia Lindskog; Adil Mardinoglu; Fredrik Ponten
Journal:  Science       Date:  2017-08-18       Impact factor: 47.728

5.  Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1.

Authors:  Atsuo Sasaki; Takaharu Taketomi; Reiko Kato; Kazuko Saeki; Atsushi Nonami; Mika Sasaki; Masamitsu Kuriyama; Naoaki Saito; Masabumi Shibuya; Akihiko Yoshimura
Journal:  Nat Cell Biol       Date:  2003-05       Impact factor: 28.824

6.  Breast cancer patients' clinical outcome measures are associated with Src kinase family member expression.

Authors:  B Elsberger; R Fullerton; S Zino; F Jordan; T J Mitchell; V G Brunton; E A Mallon; P G Shiels; J Edwards
Journal:  Br J Cancer       Date:  2010-08-17       Impact factor: 7.640

7.  SCCA1/SERPINB3 promotes oncogenesis and epithelial-mesenchymal transition via the unfolded protein response and IL6 signaling.

Authors:  Namratha Sheshadri; Joseph M Catanzaro; Alex J Bott; Yu Sun; Erica Ullman; Emily I Chen; Ji-An Pan; Song Wu; Howard C Crawford; Jianhua Zhang; Wei-Xing Zong
Journal:  Cancer Res       Date:  2014-09-11       Impact factor: 12.701

8.  A proteomic chronology of gene expression through the cell cycle in human myeloid leukemia cells.

Authors:  Tony Ly; Yasmeen Ahmad; Adam Shlien; Dominique Soroka; Allie Mills; Michael J Emanuele; Michael R Stratton; Angus I Lamond
Journal:  Elife       Date:  2014-01-01       Impact factor: 8.140

9.  The quantitative proteome of a human cell line.

Authors:  Martin Beck; Alexander Schmidt; Johan Malmstroem; Manfred Claassen; Alessandro Ori; Anna Szymborska; Franz Herzog; Oliver Rinner; Jan Ellenberg; Ruedi Aebersold
Journal:  Mol Syst Biol       Date:  2011-11-08       Impact factor: 11.429

10.  A pan-cancer proteomic perspective on The Cancer Genome Atlas.

Authors:  Rehan Akbani; Patrick Kwok Shing Ng; Henrica M J Werner; Maria Shahmoradgoli; Fan Zhang; Zhenlin Ju; Wenbin Liu; Ji-Yeon Yang; Kosuke Yoshihara; Jun Li; Shiyun Ling; Elena G Seviour; Prahlad T Ram; John D Minna; Lixia Diao; Pan Tong; John V Heymach; Steven M Hill; Frank Dondelinger; Nicolas Städler; Lauren A Byers; Funda Meric-Bernstam; John N Weinstein; Bradley M Broom; Roeland G W Verhaak; Han Liang; Sach Mukherjee; Yiling Lu; Gordon B Mills
Journal:  Nat Commun       Date:  2014-05-29       Impact factor: 14.919

View more
  3 in total

1.  Internal Standard Triggered-Parallel Reaction Monitoring Mass Spectrometry Enables Multiplexed Quantification of Candidate Biomarkers in Plasma.

Authors:  Jacob J Kennedy; Jeffrey R Whiteaker; Richard G Ivey; Aura Burian; Shrabanti Chowdhury; Chia-Feng Tsai; Tao Liu; ChenWei Lin; Oscar D Murillo; Rachel A Lundeen; Lisa A Jones; Philip R Gafken; Gary Longton; Karin D Rodland; Steven J Skates; John Landua; Pei Wang; Michael T Lewis; Amanda G Paulovich
Journal:  Anal Chem       Date:  2022-06-29       Impact factor: 8.008

2.  Proteome turnover in the bloodstream and procyclic forms of Trypanosoma brucei measured by quantitative proteomics.

Authors:  Michele Tinti; Maria Lucia S Güther; Thomas W M Crozier; Angus I Lamond; Michael A J Ferguson
Journal:  Wellcome Open Res       Date:  2019-10-09

3.  Protein Stability Buffers the Cost of Translation Attenuation following eIF2α Phosphorylation.

Authors:  Kim Schneider; Geoffrey Michael Nelson; Joseph Luke Watson; Jörg Morf; Maximillian Dalglish; Laura Martina Luh; Annika Weber; Anne Bertolotti
Journal:  Cell Rep       Date:  2020-09-15       Impact factor: 9.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.